Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease

Qi Li(China Pharmaceutical University), Haopeng Sun(China Pharmaceutical University), Wei Qu(China Pharmaceutical University), Yao Chen(Central South University), Feng Feng(China Pharmaceutical University), Siyu He(ShenZhen People’s Hospital)
European Journal of Medicinal Chemistry
September 13, 2018
10.1016/j.ejmech.2018.09.031
Cited by 200

Related Papers

Degradation of proteins by PROTACs and other strategies
|Acta Pharmaceutica Sinica B|2019|312
Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease
|European Journal of Medicinal Chemistry|2017|307
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
|Journal of Medicinal Chemistry|2019|270
Strategies for Structural Modification of Small Molecules to Improve Blood–Brain Barrier Penetration: A Recent Perspective
|Journal of Medicinal Chemistry|2021|196
Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application
|Journal of Medicinal Chemistry|2024|173